Intravenous thrombolysis (IVT) using recombinant tissue
|
|
- Terence Sherman
- 5 years ago
- Views:
Transcription
1 Intra-Arterial Thrombolysis in 100 Patients With Acute Stroke Due to Middle Cerebral Artery Occlusion Marcel Arnold, MD; Gerhard Schroth, MD; Krassen Nedeltchev, MD; Thomas Loher, MD; Luca Remonda, MD; Frank Stepper, MD; Matthias Sturzenegger, MD; Heinrich P. Mattle, MD Background and Purpose The purpose of this study was to evaluate the safety and efficacy of local intra-arterial thrombolysis (LIT) using urokinase in patients with acute stroke due to middle cerebral artery (MCA) occlusion. Methods We analyzed clinical and radiological findings and functional outcome 3 months after LIT with urokinase of 100 consecutive patients. To measure outcome, the modified Rankin scale (mrs) score was used. Results Angiography showed occlusion of the M 1 segment of the MCA in 57 patients, of the M 2 segment in 21, and of the M 3 or M 4 segment in 22. The median National Institutes of Health Stroke Scale (NIHSS) score at admission was 14, and, on average, 236 minutes elapsed from symptom onset to LIT. Forty-seven patients (47%) had an excellent outcome (mrs score 0 to 1), 21 (21%) a good outcome (mrs score 2), and 22 (22%) a poor outcome (mrs score 3 to 5). Ten patients (10%) died. Excellent or good outcome (mrs score 2) was seen in 59% of patients with M 1 or M 2 and 95% of those with M 3 or M 4 MCA occlusions. as seen on angiography was complete (thrombolysis in myocardial infarction [TIMI] grade 3) in 20% of patients and partial (TIMI grade 2) in 56% of patients. Age 60 years (P 0.05), low NIHSS score at admission (P ), and vessel recanalization (P ) were independently associated with excellent or good outcome and diabetes with poor outcome (P 0.002). Symptomatic cerebral hemorrhage occurred in 7 patients (7%). Conclusions LIT with urokinase that is administered by a single organized stroke team is safe and can be as efficacious as thrombolysis has been in large multicenter clinical trials. (Stroke. 2002;33: ) Key Words: outcome stroke, acute thrombolytic therapy urokinase Intravenous thrombolysis (IVT) using recombinant tissue plasminogen activator (rt-pa) has been shown to be an effective treatment for ischemic stroke within the first 3 hours after symptom onset. 1 Local intra-arterial thrombolysis (LIT) using recombinant prourokinase has also been found to improve outcome in patients with acute M 1 or M 2 segment occlusions of the middle cerebral artery (MCA), when administered within 6 hours. 2 Several series showed that IVT or LIT can be safely and efficaciously applied in everyday practice. 3,4 However, especially for the intra-arterial approach, data from large, homogeneous, and nonrandomized patient series are still rare. 5 Therefore we report our experience with 100 patients with MCA occlusions treated with LIT. Materials and Methods From December 1992 to November 2000, 100 consecutive patients (44 women and 56 men) with acute ischemic stroke due to MCA occlusions were treated with LIT using urokinase in our hospital. Twenty-three of these patients have been reported earlier. 6 In the same period, 55 additional patients underwent angiography and LIT for treatment of acute stroke due to occlusion of other vessels. Twenty-four of them had posterior circulation, 26 carotid, and 5 anterior cerebral artery occlusions. From January 1998 to November 2000, 168 patients with acute ischemic stroke underwent angiography. One hundred seven (64%) received LIT, but in 61 patients LIT was not performed because of the following reasons: internal carotid (n 33) or vertebral artery occlusion and contralateral vertebral hypoplasia (n 2) preventing access to the occluded intracranial vessel, no visualization of any arterial occlusion explaining the neurological deficit (n 24), and aortic dissection (n 2). Before 1998 we did not record all angiographies routinely; only those with acute stroke and LIT were noted in a separate registry. The neurological status was assessed at admission by a neurologist using the National Institutes of Health Stroke Scale (NIHSS). 7 LIT was performed if (1) clinical diagnosis of ischemic stroke was established by a neurologist; (2) baseline NIHSS score reached at least 4 points, except for isolated hemianopia or aphasia; (3) CT (n 97) or MRI (n 3) excluded intracranial hemorrhage; (4) 4-vessel cerebral angiography showed a vessel occlusion correlating to the neurological deficit; (5) the expected interval from symptom onset to LIT was 6 hours; (6) there were no individual clinical or laboratory findings advising against thrombolysis; and (7) for patients 75 years of age, their general condition before stroke was not advising against it. IVT was performed within a 3-hour time window, when intra-arterial delivery of the thrombolytic agent into the MCA was not possible because of occlusion of the ipsilateral extracranial internal carotid artery (n 6). Early signs of ischemia on CT were analyzed according to the criteria described by von Kummer et al. 8 Received November 20, 2001; final revision received February 18, 2002; accepted April 10, From the Departments of Neurology (M.A., K.N., F.S., M.S., H.P.M.) and Neuroradiology (G.S., L.R.), Inselspital, University of Berne, Switzerland. Correspondence to Heinrich Mattle, MD, Department of Neurology, University of Berne, Inselspital, Freiburgstrasse, CH-3010 Berne, Switzerland. heinrich.mattle@insel.ch 2002 American Heart Association, Inc. Stroke is available at DOI: /01.STR B7 1828
2 Arnold et al Thrombolysis in Middle Cerebral Artery Occlusion 1829 For MRI we routinely used fast spin echo and gradient echo sequences. 9 Regarding risk factors, diabetes mellitus refers to a past history of diabetes and hypertension to a history of hypertension. Selective intra-arterial digital subtraction angiography was performed on a biplane, high-resolution angiography system (Toshiba CAS 500) with a matrix of pixels. A 5.5 F-JB2 catheter (Valavanis) was inserted into the femoral artery and guided to the cerebral arteries for diagnostic 4-vessel angiography. All 100 patients were treated by LIT using a microcatheter, mostly a Fast Tracker 18 (Target Therapeutics) through the 5.5-F JB2 catheter, which was navigated into the occluded MCA. Urokinase (Urokinase HS Medac) in a mean dose of IU (range to IU) was infused directly into or near the proximal end of the occluding thrombus over 60 to 90 minutes in M 1 or M 2 occlusions. In patients with M 3 /M 4 occlusion urokinase was infused as close to the clot as possible, mostly in the M 2 segment. In 8 patients with M 1 or M 2 occlusion due to soft thrombotic material, mechanical disruption of the clot was performed in addition using a very flexible hydrophilic guidewire catheter (Silver Speed MTI or inch). The tip of the guidewire was formed in a J shape to avoid perforation of the vessel walls. Penetration and fragmentation of the thrombus was achieved by gently advancing and rotating the convex border of the J-shaped guidewire. In 2 patients without recanalization after injection of IU urokinase a percutaneous transluminal angioplasty was performed using a FasStealth balloon dilatation catheter (Target Therapeutics) with a balloon diameter of 2.00 mm. Treatment effect was documented by control angiography immediately after administration of urokinase. Eighteen patients who had been treated before publication of the International Stroke Trial results received heparin in a dose doubling the activated thromboplastin time immediately after LIT. 10 After the International Stroke Trial results were published, 250 to 500 mg aspirin was given to all patients (n 82) instead of heparin. All of the angiograms were analyzed by a neuroradiologist. was assessed on the control angiogram after LIT and classified according to thrombolysis in myocardial infarction (TIMI) grades, 11 as follows: no recanalization, TIMI grade 0; minimal recanalization, TIMI grade 1; partial recanalization, TIMI grade 2; and complete recanalization, TIMI grade 3. Collaterals were classified into the following 2 groups: poor, if none or minimal leptomeningeal anastomoses were visualized and no or minimal filling of the occluded vessel territory was seen, and good, if leptomeningeal anastomoses filled the occluded vessel territory by more than half. Classification of collaterals was possible in 98 of 100 patients. In 2 patients the digitally stored data were lost and documentation of the angiograms on films did not allow classifying the collaterals. Control CT scan or MRI was routinely performed within the first 24 hours after thrombolysis. Additional subsequent CT scans were performed in all patients with neurological deterioration. A symptomatic intracerebral hemorrhage (ICH) was defined as a homogeneous area of hemorrhage with clinical neurological deterioration. 2 We assessed infarct etiology with additional investigations if necessary and classified each patient according to the Trial of Org in Acute Stroke Treatment (TOAST) criteria. 12 Outcome was assessed by different neurologists with a clinical examination 3 months after LIT using the modified Rankin scale (mrs). 13 mrs scores of 0 or 1 were defined as excellent outcome, 2 as good, and 3 to 5 as poor. Death corresponds to mrs score of 6. The investigators were not blinded to the baseline scores and angiographic results. Statistical analysis was performed using SPSS 10 for MacIntosh statistical software (SPSS Inc, 2001). For comparison of outcome, we divided patients into 2 groups with either favorable or poor outcome, those with mrs score 2 and those with mrs score 3 to 6. The 2 test was used for cross-tabulation. Then, logistic regression analyses with a backward stepwise method were performed to determine the independent association of favorable outcome with other clinical and radiological factors. To determine predictors of recanalization, 2 test was used. To determine differences between patients with and without ICHs, a Fisher exact test was applied. For analyzing the time variable, patients were dichotomized into those mrs score at 3 months according to occluded vessel segments of the MCA. treated within 4 and 4 hours of symptom onset. A probability value of P 0.05 was considered significant. Results Demographic, Clinical, and Radiological Data The mean age of the patients was 61 years (range, 19 to 83 years). The median NIHSS score at admission was 14 and ranged from 3 to 24. The mean delay ( 1 SD) from symptom onset of cerebral ischemia to thrombolysis was minutes. Baseline CT scans showed early signs of ischemia in 41 of 97 patients (42%). In all 3 patients without CT scans, diffusion-weighted MRI showed signal abnormalities in the MCA territory. Thirty-six patients (38%) showed a dense artery sign on their initial CT scan. Angiography visualized occlusion of the M 1 segment of the MCA in 57 patients, of the M 2 segment of the MCA in 21 patients, and of the M 3 or M 4 segments of the MCA in 22 patients. Stroke etiology was cardioembolic in 62 patients. Largeartery atherosclerosis was present in 14, stroke of other determined etiology in 7, and stroke of undetermined etiology in 17 patients. Thirteen patients had a history of a previous cerebrovascular event. Nineteen patients were diabetics, 49 had hypertension, 34 had hypercholesterolemia, and 25 were current smokers. In patients with M 1 (n 57) or M 2 (n 21) occlusions, mean age was 59 years. The mean delay from symptom onset to therapy was 234 minutes; the median NIHSS score at admission was 14 (range 4 to 24). In patients with M 3 or M 4 occlusions (n 22), mean age was 66 years. The mean interval from symptoms to therapy was 245 minutes; the median NIHSS score at admission was 10 (range 3 to 17). Outcome Three months after the stroke 47 patients (47%) had recovered to mrs score 0 or 1 (excellent outcome) and 21 patients (21%) to mrs score 2 (good outcome). The outcome was poor (mrs score 3 to 5) in 22 patients (22%). Mortality was 10% (10 patients). Among the 78 patients with M 1 or M 2 occlusions, 33 (42%) had an excellent outcome at 3 months, 13 (17%) a good outcome, and 22 (28%) a poor outcome. Mortality was 13% (10 patients). In the group with M 3 or M 4 occlusions (n 22), the percentage of patients with excellent outcome was 63% (14 patients), good outcome 32% (7 patients), and poor outcome 5% (1 patient). No patient died (Figure).
3 1830 Stroke July 2002 Predictors of Clinical Outcome Logistic regression analyses showed the following independent predictors of favorable outcome: age 60 years (P 0.04), low NIHSS score at admission (P ), and vessel recanalization (P ). Diabetes mellitus was associated with a poor outcome (P 0.002). There was no association between outcome and sex, hypertension, smoking, stroke etiology, early CT signs, hyperdense MCA sign (HMCAS) on CT scan, time interval to treatment, or good or poor collaterals (Table 1). Complete recanalization (TIMI grade 3) was achieved in 20 patients (20%) and partial recanalization (TIMI grade 2) in 56 patients (56%). This corresponds to a partial or complete recanalization rate of 76%. In patients with M 1 or M 2 occlusions, the rate of complete or partial recanalization was 79% (62 of 78 patients) and in patients with M 3 or M 4 occlusions 64% (14 of 22 patients). The TIMI recanalization rates are shown in Table 2. Four of the 8 patients with M 1 or M 2 occlusion and mechanical disruption of the thrombus showed complete recanalization and 2 showed partial recanalization, with a good outcome in 3, poor outcome in 3, and death in 2 patients. Twice PTA of the MCA was performed with complete recanalization and good outcome in 1 patient and partial recanalization and death in the other. There was no association between recanalization and age, baseline NIHSS score, time to treatment, HMCAS, early signs of ischemia on CT scan, or stroke etiology. However, there was a trend toward a better recanalization in patients with good collaterals (Table 3). Hemorrhages Symptomatic ICH occurred in 7 patients (7%), 4 within 24 hours after treatment, 1 on day 2, and 2 on day 3 after thrombolysis. All ICHs occurred in patients with M 1 (4 of 57 patients) or M 2 occlusions (3 of 21 patients), which resulted in a hemorrhage rate of 9% (7 of 78 patients) for patients with M 1 or M 2 occlusions and of 0% for patients with M 3 or M 4 occlusions. Two of the 7 patients with ICHs died, 3 had a poor outcome, 1 a good outcome, and 1 an excellent outcome. There was no association between symptomatic ICH and hypertension, hypercholesterolemia, diabetes, baseline NIHSS score, time to treatment, early CT signs, good or poor recanalization, or good or poor collaterals (Table 4). Extracranial bleedings occurred in 3 patients (3%), in 2 at the puncture site of the catheter and in 1 patient from the gastrointestinal tract. None of the extracranial hemorrhages was life threatening, and none needed transfusion or surgical intervention. Discussion Outcome and Comparison With Randomized Trials Intra-arterial thrombolysis has been shown to be effective for treatment of patients with acute stroke due to occlusion of the M 1 or M 2 segment of the MCA. 2 However, there is always concern that under routine clinical conditions therapeutic TABLE 1. 3 Months Independent Predictors of Clinical Outcome at Outcome Excellent or Poor or Good Death Characteristic (mrs* 0 2) P (mrs 3 6) Total, n No. of patients Mean age, years Age 60 years 32 (80%) (20%) 40 Age 60 years 36 (60%) 24 (40%) 60 Sex Male 42 (75%) NS 14 (25%) 56 Female 26 (59%) 18 (41%) 44 Diabetes Yes 7 (37%) (63%) 19 No 61 (75%) 20 (25%) 81 Smoking Yes 18 (72%) NS 7 (28%) 25 No 50 (67%) 25 (33%) 75 Hypercholesterolemia Yes 28 (82%) NS 6 (18%) 34 No 40 (61%) 26 (39%) 66 Hypertension Yes 31 (63%) NS 18 (39%) 49 No 37 (73%) 14 (27%) 51 NIHSS on admission (100%) (68%) 12 (32%) (49%) 20 (51%) 39 Time delay 4 hours 36 (72%) NS 14 (28%) 50 4 hours 32 (64%) 18 (36%) 50 CT HMCAS Yes 23 (64%) NS 13 (36%) 36 No 44 (72%) 17 (28%) 61 CT early signs of ischemia Yes 25 (61%) NS 16 (39%) 41 No 42 (75%) 14 (25%) 56 TIMI 0 or 1 13 (54%) (46%) 24 TIMI 2 35 (63%) 21 (37%) 56 TIMI 3 20 (100%) 0 20 Collaterals Good 43 (72%) NS 17 (28%) 60 Poor 24 (63%) 14 (37%) 38 Stroke etiology Cardioembolic 42 (65%) NS 20 (35%) 62 Unknown 12 (71%) 5 (29%) 17 Large artery disease 11 (79%) 3 (21%) 14 Others 3 (43%) 4 (57%) 7 *P difference between subgroups by Pearson 2 test after logistic regression analysis.
4 Arnold et al Thrombolysis in Middle Cerebral Artery Occlusion 1831 TABLE 2. TIMI Grades According to the Occluded Segments of the MCA TIMI M 1 /M 2 Occlusions M 3 /M 4 Occlusions 0 or 1 21% 36% 2 56% 55% 3 23% 9% intervention may have higher risks and be less effective than under trial conditions. Our results with 59% excellent or good outcomes (mrs score 2) in patients with M 1 or M 2 occlusions and 96% excellent or good outcomes in patients with M 3 or M 4 occlusions indicate that LIT using urokinase can be safe and efficacious when applied by a well-organized stroke team. The proportion of our patients with M 1 or M 2 occlusions who regained functional independence was even higher than in the Prolyse in Acute Cerebral Thromboembolism (PROACT) II study (59% versus 40%), and mortality was lower (13% versus 25%). 2 These differences might be explained by the lower median baseline NIHSS score of our patients compared with the PROACT II patients (14 versus 17). In addition, the younger age (59 versus 64 years) and the lower median time to treatment (3.9 hours versus 5.3 hours) favored our patients. TABLE 3. Predictors of Vessel Vessel Sufficient Insufficient Characteristic (TIMI 2 or 3) P (TIMI 0 or 1) Total, n No. of patients Mean age, years NIHSS score on admission (75%) NS* 6 (25%) (76%) 9 (24%) (77%) 9 (23%) 39 Time delay 4 hours 38 (76%) NS 12 (24%) 50 4 hours 38 (76%) 12 (24%) 50 CT HMCAS Yes 27 (75%) NS 9 (25%) 36 No 49 (80%) 12 (20%) 61 CT early signs of ischemia Yes 30 (73%) NS 11 (27%) 41 No 43 (77%) 13 (23%) 56 Collaterals Good 49 (82%) NS 11 (18%) 60 Poor 25 (66%) 13 (34%) 38 Stroke etiology Cardioembolic 47 (76%) NS 15 (24%) 62 Unknown 13 (76%) 4 (24%) 17 Large artery disease 10 (71%) 4 (29%) 14 Others 6 (86%) 1 (14%) 7 *NS indicates nonsignificant difference between subgroups by Pearson 2 test. TABLE 4. Predictors of Symptomatic Cerebral Hemorrhage Symptomatic Cerebral Hemorrhage Characteristic Present P Absent Total, n No. of patients Mean age, years Diabetes Yes 2 (11%) NS* 17 (89%) 19 No 5 (6%) 76 (94%) 81 Hypercholesterolemia Yes 3 (9%) NS 31 (91%) 34 No 4 (6%) 62 (94%) 66 Hypertension Yes 5 (10%) NS 44 (90%) 49 No 2 (4%) 49 (96%) 51 NIHSS score on admission 10 1 (4%) NS 23 (96%) (14%) 32 (86%) (3%) 38 (97%) 39 Time delay 4 hours 6 (12%) NS 44 (88%) 50 4 hours 1 (2%) 49 (98%) 50 CT early signs of ischemia Yes 3 (7%) NS 38 (93%) 41 No 3 (5%) 53 (95%) 56 TIMI 0 or 1 2 (8%) NS 22 (92%) 24 TIMI 2 or 3 5 (7%) 71 (93%) 76 Collaterals Good 4 (7%) NS 56 (93%) 60 Poor 3 (8%) 35 (92%) 38 *NS indicates nonsignificant difference between subgroups by Fisher exact test. Differences in patient selection, vessel territories involved, and stroke subtypes limit a comparison with the NINDS trial using intravenous rt-pa. The percentage of our patients with minimal or no disability (mrs score 1) was higher than in the NINDS study (47% versus 42%) despite earlier treatment (within 3 hours of symptom onset) in NINDS and an identical median baseline NIHSS score of 14 in both studies. In addition, the mortality of 10% at 3 months in our patients was lower than that of the NINDS trial (17%). In a recent small subgroup analysis from an IVT open-label study, only 30% of 20 patients with M 1 occlusions diagnosed by transcranial Doppler ultrasound recovered to mrs score 0 to 2, indicating that IVT is probably less effective than LIT when the MCA main stem is occluded. 14 In the patients with M 3 or M 4 occlusions, only 1 of 22 patients (5%) had a poor outcome and there were no deaths. The results are encouraging but do not allow a statement about efficacy in these patients because of the lack of a control group. It is probable that the good results are due to mild neurological deficits before LIT (median NIHSS score 10) and a spontaneous benign course in these patients.
5 1832 Stroke July 2002 Predictors of Outcome In our series, patients younger than 60 years, with low baseline NIHSS score before thrombolysis, and with successful recanalization had a significantly better outcome than other patients. Each of these 3 factors was an independent predictor of favorable outcome. This is consistent with observations in NINDS and other patient series. 1,15,16 On the other hand, diabetes mellitus was an independent predictor of unfavorable outcome in our series. Jorgensen et al 17 reported that high glucose concentration was an independent predictor of poor outcome in stroke patients. It has been shown that hyperglycemia is related to decreased cerebral blood flow and cerebrovascular reserve and to cellular acidosis in ischemic tissue. 18,19 The time from symptom onset to treatment did not exert an independent effect on the clinical outcome in our patients treated within 6 hours. It may indicate that some patients may have sufficient collaterals to preserve a large penumbra for a prolonged period of several hours. The missing correlation between the time to treatment and outcome also questions the current concept of a 6-hour therapeutic time window for intra-arterial thrombolysis. If the hypothesis of collaterals that preserve a large penumbra is true, a correlation between well-visualized collaterals on the arteriogram and outcome should be observed. There was only a nonsignificant trend that well-visualized collaterals on the arteriogram correlated with a better outcome. A potential explanation for this might be a methodological problem. In both the anteroposterior and the lateral view of the arteriogram, collaterals are always superimposed on normal arteries, which makes it difficult to assess the amount of functioning collaterals in the individual patient. MRI with perfusion- and diffusion-weighted imaging might help more to select patients with good collaterals who might benefit from LIT even after a long interval from onset of symptoms, eg, patients with a large volume of reduced perfusion and at the same time a small volume of abnormal diffusion. 20 There was no independent association between sex, hypertension, smoking, hypercholesterolemia, stroke etiology, early CT signs, HMCAS on CT scan or amount of collaterals, and outcome in our patients. There were nonsignificant trends toward better outcomes in men, patients without hypertension, patients treated within 4 hours, patients without HMCAS and without early signs of ischemia on CT scan, and patients with better collaterals. These results should be interpreted with caution and should not influence clinical decisions because of the small sample size. The partial or complete recanalization rate was 76% for all MCA patients, 79% for patients with M 1 or M 2 occlusions, and 64% for those with M 3 or M 4 occlusions. These results are in the upper range of the rates of randomized trials 2,21 and other open LIT series with various agents and vascular territories, 4,15,22,23 in which recanalization rates from 58% to 100% were reported. Partial or complete recanalization of 66% in PROACT II was lower than in this series with 79%. Mechanical disruption of the clot or PTA, in addition to pharmacological thrombolysis, was performed in 10 patients in this series, whereas this was not permitted in PROACT II. A nonsignificant trend toward better recanalization in M 1 /M 2 occlusions was observed compared with M 3 /M 4 occlusions. Potential explanations are direct infusions of urokinase into the clot with M 1 /M 2 occlusions, which was not possible in M 3 /M 4 occlusions. In addition, mechanical disruption or PTA led to recanalization in 7 patients with M 1 /M 2 occlusions. There may also be hemodynamic reasons. The blood flow pressure gradient in the MCA mainstem is higher than in the periphery, and therefore the force to dislodge the clot might be greater. It was not possible to identify predictors of recanalization, except for a nonsignificant trend toward better recanalization when sufficient collaterals were observed (Table 2). The missing association between recanalization and collaterals, baseline NIHSS score, time to treatment, HMCAS, and stroke etiology might be explained by the fact that the size of the thrombus or embolus and its composition might determine the likelihood of recanalization. Unfortunately, methods to assess these factors reliably in clinical medicine have yet to be created. Another explanation might be the small number of patients in our series. Symptomatic ICH Our rate of symptomatic ICH (7%) is on the same order of that of the NINDS cohort (6.4%) and other randomized intravenous rt-pa trials 24,25 and the intra-arterial PROACT II trial (10.2%). If patients at high risk of cerebral bleeding can be identified and excluded from thrombolysis, then the safety and outcome from thrombolysis could be optimized. In this series we could not find any factors predicting ICH. This result may be due to the small sample size, because in the NINDS trial patients with a high baseline NIHSS score and those with clear edema or mass effect on early CT changes were at higher risk of bleeding than other patients. 26 Comparison of LIT and IVT Direct comparisons of LIT and IVT have not been performed to date. Assessing the angiographic recanalization rates in MCA occlusions, del Zoppo et al 27 found 26% (12 of 46 vessels) complete or partial recanalizations after IVT for MCA main stem occlusion. Burgin et al 28 reported a 60% complete or partial angiographic recanalization rate after IVT in 25 patients with MCA occlusions. In PROACT 66% of MCAs have been recanalized, and in this series 79% of M 1 or M 2 occlusions have been recanalized. Because there is a correlation between recanalization and outcome, a cautious conclusion would be that the intra-arterial approach seems to be as effective as IVT when the main stem of the MCA is occluded. In peripheral occlusions (ie, M 3 and M 4 segments), such data allowing a comparison of IVT and LIT are lacking. Limitations Our study has some limitations. First, it is a retrospective review. Second, the follow-up examinations were not blinded Third, the study population might not be representative for the whole stroke population because of a referral bias that
6 Arnold et al Thrombolysis in Middle Cerebral Artery Occlusion 1833 favors younger patients. Younger patients are more likely referred to a stroke center than older patients. Conclusion Our results indicate that LIT used by an organized stroke team in a routine clinical setting can be safe and efficacious in patients with M 1 or M 2 occlusions. It remains unclear whether the good results in M 3 or M 4 occlusions are due to thrombolysis or to a benign spontaneous course. Further research is needed to answer this question and to compare LIT with IVT or even a combined intra-arterial/intravenous approach. 29 Acknowledgment We thank Pietro Ballinari, PhD, for statistical advice. References 1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. N Engl J Med. 1995;333: Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark MW, Silver F, Rivera F, for the PROACT investigators. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999;282: Schmuelling S, Grond M, Rudolf J, Heiss WD. One-year follow-up in acute stroke patients treated with rtpa in clinical routine. Stroke. 2000; 31: Theron J, Coskun O, Huet H, Oliveira G, Toulas P, Payelle G. Local intraarterial thrombolysis in the carotid territory. Intervent Neuroradiol. 1996;2: Suarez JI, Sunshine JL, Tarr R, Zaidat O, Selman WR, Kernich C, Landis DM. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke. 1999;30: Gönner F, Remonda L, Mattle H, Sturzenegger M, Ozdoba C, Lövblad KO, Baumgartner R, Bassetti C, Schroth G. Local intra-arterial thrombolysis in acute stroke. Stroke. 1998;29: Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Roorick M, Moomaw CJ, Walker M. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20: von Kummer R, Allen KL, Holle R, Bozzao L, Bastianello S, Manelfe C, Bluhmki E, Ringleb P, Meier DH, Hacke W. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology 1997;205: Lin DD, Filippi CG, Steever AB, Zimmerman RD. Detection of intracranial hemorrhage: comparison between gradient-echo images and b(0) images obtained from diffusion-weighted echo-planar sequences. AJNR Am J Neuroradiol. 2001;22: The International Stroke Trial. A randomised trial of aspirin, subcutaneous heparin, both, or neither among patients with acute ischaemic stroke: International Stroke Trial Collaborative Group. Lancet. 1997;349: The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings: TIMI Study Group. N Engl J Med. 1985;312: Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd, and the TOAST investigators. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org in Acute Stroke Treatment. Stroke. 1993; 24: van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19: Schneweis S, Grond M, Neveling M, Schmuelling S, Rudolf J, Heiss WD. Intravenous thrombolysis in proximal middle cerebral artery occlusion. Cerebrovasc Dis. 2001;11: Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke. 1988; 19: Von Kummer R, Holle R, Rosin L, Forsting M, Hacke W. Does arterial recanalization improve outcome in carotid territory stroke? Stroke. 1995; 26: Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes: the Copenhagen stroke study. Stroke. 1994;25: Fulesdi B, Limburg M, Bereczki D, Kaplar M, Molnar C, Kappelmayer J, Neuwirth G, Csiba L. Cerebrovascular reactivity and reserve capacity in type II diabetes mellitus. J Diabetes Complications. 1999;13: Wagner KR, Kleinholz M, de Courten-Myers GM, Myers RE. Hyperglycemic versus normoglycemic stroke: topography of brain metabolites, intracellular ph, and infarct size. J Cereb Blood Flow Metab. 1992;12: Warach S. New imaging strategies for patient selection for thrombolytic and neuroprotective therapies. Neurology. 2001;57:S48 S del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M, and the PROACT Investigators. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators Prolyse in Acute Cerebral Thromboembolism. Stroke. 1998;29: Sasaki O, Takeuchi S, Koike T, Koizumi T, Tanaka R. Fibrinolytic therapy for acute embolic stroke: intravenous, intracarotid, and intra-arterial local approaches. Neurosurgery. 1995;36: Casto L, Caverni L, Camerlingo M, Censori B, Moschini L, Servalli MC, Partziguian T, Belloni G, Mamoli A. Intra-arterial thrombolysis in acute ischaemic stroke: experience with a superselective catheter embedded in the clot. J Neurol Neurosurg Psychiatry. 1996;60: Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352: Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS Study: a randomised controlled trial: Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA. 1999;282: Intracerebral hemorrhage after intravenous t-pa therapy for ischemic stroke: the NINDS t-pa Stroke Study Group. Stroke. 1997;28: del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Bilier J, Gress D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992;32: Burgin WS, Malkoff M, Felberg RA, Mechuk AM, Christou I, Grotta JC, Alexandrov AV. Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke. Stroke. 2000; 31: Ernst R, Pancioli A, Tomsick T, Kissela B, Woo D, Kanter D, Jauch E, Carrozzella J, Spilker J, Broderick J. Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke. 2000;31:
An intravenous thrombolysis using recombinant tissue
ORIGINAL RESEARCH I. Ikushima H. Ohta T. Hirai K. Yokogami D. Miyahara N. Maeda Y. Yamashita Balloon Catheter Disruption of Middle Cerebral Artery Thrombus in Conjunction with Thrombolysis for the Treatment
More informationThe National Institutes of Health Stroke Scale (NIHSS)
National Institutes of Health Stroke Scale Score and Vessel Occlusion in 252 Patients With Acute Ischemic Stroke Mirjam R. Heldner, MD; Christoph Zubler, MD; Heinrich P. Mattle, MD; Gerhard Schroth, MD;
More informationJudicious use of thrombolytic agents has greatly improved the
Predictors of Clinical Improvement, Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke J.I. Suarez, MD; J.L. Sunshine, MD; R. Tarr, MD;
More informationIntravenous (IV) recombinant tissue plasminogen activator
Combined Intravenous and Intra-Arterial Recanalization for Acute Ischemic Stroke: The Interventional Management of Stroke Study The IMS Study Investigators Background and Purpose To investigate the feasibility
More informationIntra-arterial thrombolysis (IAT) has the potential to rescue
Published September 3, 2008 as 10.3174/ajnr.A1276 ORIGINAL RESEARCH G.A. Christoforidis C. Karakasis Y. Mohammad L.P. Caragine M. Yang A.P. Slivka Predictors of Hemorrhage Following Intra-Arterial Thrombolysis
More informationSince the National Institute of Neurologic Disorders and
ORIGINAL RESEARCH R.M. Sugg E.A. Noser H.M. Shaltoni N.R. Gonzales M.S. Campbell R. Weir E.D. Cacayorin J.C. Grotta Intra-Arterial Reteplase Compared to Urokinase for Thrombolytic Recanalization in Acute
More informationAlthough intravenous (IV) thrombolysis has gained wide
Intravenous Versus Combined (Intravenous and Intra-Arterial) Thrombolysis in Acute Ischemic Stroke A Transcranial Color-Coded Duplex Sonography Guided ilot Study Lucka Sekoranja, MD; Jaouad Loulidi, MD;
More informationThe principal goal in treating acute ischemic stroke is rapid
ORIGINAL RESEARCH S. Sugiura K. Iwaisako S. Toyota H. Takimoto Simultaneous Treatment with Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Acute Ischemic Stroke Within
More informationENDOVASCULAR THERAPIES FOR ACUTE STROKE
ENDOVASCULAR THERAPIES FOR ACUTE STROKE Cerebral Arteriogram Cerebral Anatomy Cerebral Anatomy Brain Imaging Acute Ischemic Stroke (AIS) Therapy Main goal is to restore blood flow and improve perfusion
More informationDistal arterial emboli may be sequelae of intravenous (IV)
ORIGINAL RESEARCH S. King P. Khatri J. Carrozella J. Spilker J. Broderick M. Hill T. Tomsick, for the IMS & IIMS II Investigators Anterior Cerebral Artery Emboli in Combined Intravenous and Intra-arterial
More informationBY MARILYN M. RYMER, MD
Lytics, Devices, and Advanced Imaging The evolving art and science of acute stroke intervention. BY MARILYN M. RYMER, MD In 1996, when the US Food and Drug Administration (FDA) approved the use of intravenous
More informationPrognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score before Ultraearly Thrombolytic Therapy
Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score before Ultraearly Thrombolytic Therapy Thomas Tomsick, Thomas Brott, William Barsan, Joseph Broderick, E. Clarke Haley,
More informationSymptomatic intracerebral hemorrhage (sich) after
Reduced Pretreatment Ipsilateral Middle Cerebral Artery Cerebral Blood Flow Is Predictive of Symptomatic Hemorrhage Post Intra-Arterial Thrombolysis in Patients With Middle Cerebral Artery Occlusion Rishi
More informationAn Updated Systematic Review of rt-pa in Acute Ischaemic Stroke
Wardlaw An Updated Systematic Review of rt-pa in Acute Ischaemic Stroke Joanna M Wardlaw COMPETING INTERESTS The author is on the Steering Committees of the Third International Stroke Trial (IST3) and
More informationNoncontrast computed tomography (CT) reliably distinguishes
Extent of Early Ischemic Changes on Computed Tomography (CT) Before Thrombolysis Prognostic Value of the Alberta Stroke Program Early CT Score in ECASS II Imanuel Dzialowski, MD; Michael D. Hill, MD, MSc,
More informationThe term minor stroke is often used for stroke patients
What Is a Minor Stroke? Urs Fischer, MD, MSc; Adrian Baumgartner, MS; Marcel Arnold, MD; Krassen Nedeltchev, MD; Jan Gralla, MD, MSc; Gian Marco De Marchis, MD; Liliane Kappeler, MD; Marie-Luise Mono,
More informationIntravenous tpa has been a mainstay of acute stroke
J Neurosurg 115:359 363, 2011 Aggressive intervention to treat a young woman with intracranial hemorrhage following unsuccessful intravenous thrombolysis for left middle cerebral artery occlusion Case
More informationCerebrovascular Disease lll. Acute Ischemic Stroke. Use of Intravenous Alteplace in Acute Ischemic Stroke Louis R Caplan MD
Cerebrovascular Disease lll. Acute Ischemic Stroke Use of Intravenous Alteplace in Acute Ischemic Stroke Louis R Caplan MD Thrombolysis was abandoned as a stroke treatment in the 1960s due to an unacceptable
More informationThrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome
AJNR Am J Neuroradiol 26:880 884, April 2005 Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome Osama O. Zaidat, Jose I. Suarez, Jeffrey L.
More informationClinical benefit of tissue plasminogen activator (tpa) in
Thrombolysis in Brain Ischemia (TIBI) Transcranial Doppler Flow Grades Predict Clinical Severity, Early Recovery, and Mortality in Patients Treated With Intravenous Tissue Plasminogen Activator Andrew
More informationThrombolysis in acute stroke
152 Thrombolysis in acute stroke Cerebrovascular disease has a major impact on people s physical, social and mental well-being, and is a major financial burden on the NHS. In recent times, the management
More informationCombined Intraarterial/Intravenous Thrombolysis for Acute Ischemic Stroke
AJNR Am J Neuroradiol 22:52 58, February Combined Intraarterial/Intravenous Thrombolysis for Acute Ischemic Stroke Valdis Keris, Svetlana Rudnicka, Vladimirs Vorona, Gertrude Enina, Biruta Tilgale, and
More informationInterrater Reliability and Sensitivity of CT Interpretation by Physicians Involved in Acute Stroke Care
Detection of Early CT Signs of >1/3 Middle Cerebral Artery Infarctions Interrater Reliability and Sensitivity of CT Interpretation by Physicians Involved in Acute Stroke Care Mary A. Kalafut, MD; David
More informationNHL Journal of Medical Sciences/July 2014/Vol 3/Issue 2 18
Research article NIHSS Score: A handy tool to predict vascular occlusion in acute ischemic stroke Ronak Shah*, Chintal Vyas**, Jyoti Vora*** *Senior Resident, **Assistant Professor, ***Associate Professor,
More informationThrombolytic Therapy in Clinical Practice The Norwegian Experience
Thrombolytic Therapy in Clinical Practice The Norwegian Experience Thomassen Lars Thomassen, Ulrike Waje-Andreassen, Halvor Næss ABSTRACT Background: Awaiting the European approval of thrombolysis, we
More informationI schaemic stroke is currently the third leading cause
1426 PAPER The probability of middle cerebral artery MRA flow signal abnormality with quantified CT ischaemic change: targets for future therapeutic studies P A Barber, A M Demchuk, M D Hill, J H Warwick
More informationEarly computed tomographic (CT) ischemic change in the
Hyperdense Sylvian Fissure MCA Dot Sign A CT Marker of Acute Ischemia Philip A. Barber, MRCP(UK); Andrew M. Demchuk, FRCPC; Mark E. Hudon, FRCPC; J.H. Warwick Pexman, FRCPC; Michael D. Hill, FRCPC; Alastair
More informationThe National Institutes of Health Stroke Scale (NIHSS)
National Institutes of Health Stroke Scale Score and Vessel Occlusion in 2152 Patients With Acute Ischemic Stroke Mirjam R. Heldner, MD; Christoph Zubler, MD; Heinrich P. Mattle, MD; Gerhard Schroth, MD;
More informationArterial Occlusion Revealed by CT Angiography Predicts NIH Stroke Score and Acute Outcomes after IV tpa Treatment
AJNR Am J Neuroradiol 26:246 251, February 2005 Arterial Occlusion Revealed by CT Angiography Predicts NIH Stroke Score and Acute Outcomes after IV tpa Treatment John R. Sims, Guy Rordorf, Eric E. Smith,
More informationCurrent treatment options for acute ischemic stroke include
ORIGINAL RESEARCH M.-N. Psychogios A. Kreusch K. Wasser A. Mohr K. Gröschel M. Knauth Recanalization of Large Intracranial Vessels Using the Penumbra System: A Single-Center Experience BACKGROUND AND PURPOSE:
More informationSafety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
Original Article Medical Journal of the Islamic Republic of Iran, Vol. 27, No. 3, Aug 2013, pp. 113-118 Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic
More informationSequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke
AJNR Am J Neuroradiol 25:1470 1475, October 2004 Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke Kyung Yul Lee, Dong
More informationIntra-arterial thrombolysis has improved the prognosis of
Mechanical Thrombectomy for Acute Ischemic Stroke Thrombus Device Interaction, Efficiency, and Complications In Vivo Jan Gralla, MD; Gerhard Schroth, MD; Luca Remonda, MD; Krassen Nedeltchev, MD; Johannes
More informationOutcomes of intravenous thrombolysis in posterior versus anterior circulation stroke
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse CH-0 Zurich www.zora.uzh.ch Year: 0 Outcomes of intravenous thrombolysis in posterior versus anterior circulation stroke
More informationEFFICACY AND SAFETY OF INTRA-ARTERIAL THROMBOLYTIC
Open Access Research Journal Medical and Health Science Journal, MHSJ www.pradec.eu ISSN: 1804-1884 (Print) 1805-5014 (Online) Volume 10, 2012, pp. 2-9 EFFICACY AND SAFETY OF INTRA-ARTERIAL THROMBOLYTIC
More informationDirect Percutaneous Transluminal Angioplasty for Acute Middle Cerebral Artery Trunk Occlusion. An Alternative Option to Intra-arterial Thrombolysis
Direct Percutaneous Transluminal Angioplasty for Acute Middle Cerebral Artery Trunk Occlusion An Alternative Option to Intra-arterial Thrombolysis Shinichi Nakano, MD; Tsutomu Iseda, MD; Takumi Yoneyama,
More informationPARADIGM SHIFT FOR THROMBOLYSIS IN PATIENTS WITH ACUTE ISCHAEMIC STROKE, FROM EXTENSION OF THE TIME WINDOW TO RAPID RECANALISATION AFTER SYMPTOM ONSET
PARADIGM SHIFT FOR THROMBOLYSIS IN PATIENTS WITH ACUTE ISCHAEMIC STROKE, FROM EXTENSION OF THE TIME WINDOW TO RAPID RECANALISATION AFTER SYMPTOM ONSET Hye Seon Jeong, *Jei Kim Department of Neurology and
More informationTrial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke
Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke Randall T. Higashida, MD; Anthony J. Furlan, MD; for the Technology Assessment Committees of the
More informationAngiographic Assessment of Pial Collaterals as a Prognostic Indicator Following Intra-arterial Thrombolysis for Acute Ischemic Stroke
AJNR Am J Neuroradiol 26:1789 1797, August 2005 Angiographic Assessment of Pial Collaterals as a Prognostic Indicator Following Intra-arterial Thrombolysis for Acute Ischemic Stroke Gregory A. Christoforidis,
More informationEndovascular stroke treatments are being increasingly used
Published March 18, 2010 as 10.3174/ajnr.A2050 ORIGINAL RESEARCH A.C. Flint S.P. Cullen B.S. Faigeles V.A. Rao Predicting Long-Term Outcome after Endovascular Stroke Treatment: The Totaled Health Risks
More informationThrombus Localization with Emergency Cerebral CT
Thrombus Localization with Emergency Cerebral CT Thomas Tomsick, ' Thomas Brott, William Barsan, Joseph Broderick, E. Clarke Haley, and Judith Spilker Purpose: To determine the prevalence of the hyperdense
More informationComparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion # 3 h and 3-6 h
Original Article Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion # 3 h and 3-6 h Yue-Hua Li, Ming-Hua Li, Zhen-Guo Zhao 1, Qing-Ke Bai 1 Department of Radiology,
More informationIntracranial Balloon Angioplasty of Acute Terminal Internal Carotid Artery Occlusions
AJNR Am J Neuroradiol 23:1308 1312, September 2002 Case Report Intracranial Balloon Angioplasty of Acute Terminal Internal Carotid Artery Occlusions Joon K. Song, Edwin D. Cacayorin, Morgan S. Campbell,
More informationNeurological Deterioration in Acute Ischemic Stroke
Neurological Deterioration in Acute Ischemic Stroke Potential Predictors and Associated Factors in the European Cooperative Acute Stroke Study (ECASS) I A. Dávalos, MD; D. Toni, MD; F. Iweins, MSc; E.
More informationSpontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke
Original Contribution Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke Abstract Introduction: Acute carotid artery occlusion carries
More informationClinical Features of Patients Who Come to Hospital at the Super Acute Phase of Stroke
Research Article imedpub Journals http://www.imedpub.com Clinical Features of Patients Who Come to Hospital at the Super Acute Phase of Stroke Abstract Background: The number of patients who are adopted
More informationThe Fate of High-Density Lesions on the Non-contrast CT Obtained Immediately After Intra-arterial Thrombolysis in Ischemic Stroke Patients
The Fate of High-Density Lesions on the Non-contrast CT Obtained Immediately After Intra-arterial Thrombolysis in Ischemic Stroke Patients Yu Mi Jang, MD Deok Hee Lee, MD Ho Sung Kim, MD Chang Woo Ryu,
More informationEarly recanalization reduces mortality and improves outcome
ORIGINAL RESEARCH C. Brekenfeld G. Schroth P. Mordasini U. Fischer M.-L. Mono A. Weck M. Arnold M. El-Koussy J. Gralla Impact of Retrievable Stents on Acute Ischemic Stroke Treatment BACKGROUND AND PURPOSE:
More informationThe prognosis for acute basilar artery occlusion (BAO) is
Published July 17, 2014 as 10.3174/ajnr.A4045 ORIGINAL RESEARCH INTERVENTIONAL Forced Arterial Suction Thrombectomy with the Penumbra Reperfusion Catheter in Acute Basilar Artery Occlusion: A Retrospective
More informationCorrelation of Early CT Signs in the Deep Middle Cerebral Artery Territories with Angiographically Confirmed Site of Arterial Occlusion
AJNR Am J Neuroradiol 22:65 659, April 2 Correlation of Early CT Signs in the Deep Middle Cerebral Artery Territories with Angiographically Confirmed Site of Arterial Occlusion Shinichi Nakano, Tsutomu
More information7 TI - Epidemiology of intracerebral hemorrhage.
1 TI - Multiple postoperative intracerebral haematomas remote from the site of craniotomy. AU - Rapana A, et al. SO - Br J Neurosurg. 1998 Aug;1():-8. Review. IDS - PMID: 1000 UI: 991958 TI - Cerebral
More informationEndovascular Recanalization Therapy in Acute Ischemic Stroke
Endovascular Recanalization Therapy in Acute Ischemic Stroke Jae H. Choi, MD; Brian T. Bateman, BA; Sundeep Mangla, MD; Randolph S. Marshall, MD; Shyam Prabhakaran, MD; Ji Chong, MD; Jay P. Mohr, MD; Henning
More informationAlex Abou-Chebl, MD Associate Professor of Neurology and Neurosurgery Director of Neurointerventional Services Director of Vascular and
Alex Abou-Chebl, MD Associate Professor of Neurology and Neurosurgery Director of Neurointerventional Services Director of Vascular and Interventional Neurology Fellowships University of Louisville School
More informationMechanical Thrombectomy Using a Solitaire Stent in Acute Ischemic Stroke; Initial Experience in 40 Patients
Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2012.14.3.164 Original Article Mechanical Thrombectomy Using a Solitaire Stent in
More informationComparison of Five Major Recent Endovascular Treatment Trials
Comparison of Five Major Recent Endovascular Treatment Trials Sample size 500 # sites 70 (100 planned) 316 (500 planned) 196 (833 estimated) 206 (690 planned) 16 10 22 39 4 Treatment contrasts Baseline
More informationCT-Based Assessment of Acute Stroke. CT, CT Angiography, and Xenon-Enhanced CT Cerebral Blood Flow
CT-Based Assessment of Acute Stroke CT, CT Angiography, and Xenon-Enhanced CT Cerebral Blood Flow Megan M. Kilpatrick, BS; Howard Yonas, MD; Steven Goldstein, MD; Amin B. Kassam, MD; James M. Gebel, Jr,
More informationAnalysis of DWI ASPECTS and Recanalization Outcomes of Patients with Acute-phase Cerebral Infarction
J Med Dent Sci 2012; 59: 57-63 Original Article Analysis of DWI ASPECTS and Recanalization Outcomes of Patients with Acute-phase Cerebral Infarction Keigo Shigeta 1,2), Kikuo Ohno 1), Yoshio Takasato 2),
More informationACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS. Justin Nolte, MD Assistant Profession Marshall University School of Medicine
ACUTE STROKE TREATMENT IN LARGE NIHSS PATIENTS Justin Nolte, MD Assistant Profession Marshall University School of Medicine History of Presenting Illness 64 yo wf with PMHx of COPD, HTN, HLP who was in
More informationBiomed Pap Med Fac Univ Palacky Olomouc Czech Repub Sep; 158(3):
The safety and efficacy of bridging full-dose IV-IA thrombolysis in acute ischemic stroke patients with MCA occlusion: A comparison with IV thrombolysis alone Daniel Sanak a, Martin Kocher b, Tomas Veverka
More informationComparative Analysis of Endovascular Stroke Therapy Using Urokinase, Penumbra System and Retrievable (Solitare) Stent
www.jkns.or.kr http://dx.doi.org/10.3340/jkns.2015.57.5.342 J Korean Neurosurg Soc 57 (5) : 342-349, 2015 Print ISSN 2005-3711 On-line ISSN 1598-7876 Copyright 2015 The Korean Neurosurgical Society Clinical
More informationDisclosures. Anesthesia for Endovascular Treatment of Acute Ischemic Stroke. Acute Ischemic Stroke. Acute Stroke = Medical Emergency!
Disclosures Anesthesia for Endovascular Treatment of Acute Ischemic Stroke I have nothing to disclose. Chanhung Lee MD, PhD Associate Professor Anesthesia and perioperative Care Acute Ischemic Stroke 780,000
More informationEFFECT OF OLDER AGE ON THE RISK OF HEMORRHAGIC COMPLICATIONS AFTER INTRAVENOUS AND/OR INTRA-ARTERIAL THROMBOLYSIS FOR ACUTE ISCHEMIC STROKE
EFFECT OF OLDER AGE ON THE RISK OF HEMORRHAGIC COMPLICATIONS AFTER INTRAVENOUS AND/OR INTRA-ARTERIAL THROMBOLYSIS FOR ACUTE ISCHEMIC STROKE By SVETLANA PUNDIK, M.D. Submitted in partial fulfillment of
More informationIMAGING IN ACUTE ISCHEMIC STROKE
IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;
More informationThromboembolic occlusion of major cerebral arteries is
ORIGINAL RESEARCH Z. Kulcsár C. Bonvin V.M. Pereira S. Altrichter H. Yilmaz K.O. Lövblad R. Sztajzel D.A. Rüfenacht Penumbra System: A Novel Mechanical Thrombectomy Device for Large-Vessel Occlusions in
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More informationACUTE STROKE INTERVENTION: THE ROLE OF THROMBECTOMY AND IA LYSIS
Associate Professor of Neurology Director of Neurointerventional Services University of Louisville School of Medicine ACUTE STROKE INTERVENTION: THE ROLE OF THROMBECTOMY AND IA LYSIS Conflict of Interest
More informationReview Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials Steven Warach
Review Use of diffusion and perfusion magnetic resonance imaging as a tool in acute stroke clinical trials Steven Warach Section on Stroke Diagnostics and Therapeutics, National Institute of Neurological
More informationThrombolytic Therapy in Acute Occlusion of the Intracranial Internal Carotid Artery Bifurcation
Thrombolytic Therapy in Acute Occlusion of the Intracranial Internal Carotid Artery Bifurcation Olav Jansen, Rüdiger von Kummer, Michael Forsting, Werner Hacke, and Klaus Sartor PURPOSE: To evaluate efficacy
More informationPractical Considerations in the Early Treatment of Acute Stroke
Practical Considerations in the Early Treatment of Acute Stroke Matthew E. Fink, MD Neurologist-in-Chief Weill Cornell Medical College New York-Presbyterian Hospital mfink@med.cornell.edu Disclosures Consultant
More informationACUTE STROKE IMAGING
ACUTE STROKE IMAGING Mahesh V. Jayaraman M.D. Director, Inter ventional Neuroradiology Associate Professor Depar tments of Diagnostic Imaging and Neurosurger y Alper t Medical School at Brown University
More informationResults of Urgent Thrombolysis in Patients with Major Stroke and Atherothrombotic Occlusion of the Cervical Internal Carotid Artery
AJNR Am J Neuroradiol 19:1169 1175, June 1998 Results of Urgent Thrombolysis in Patients with Major Stroke and Atherothrombotic Occlusion of the Cervical Internal Carotid Artery Shunro Endo, Naoya Kuwayama,
More informationDiagnostic and Therapeutic Consequences of Repeat Brain Imaging and Follow-up Vascular Imaging in Stroke Patients
AJNR Am J Neuroradiol 0:7, January 999 Diagnostic and Therapeutic Consequences of Repeat Brain Imaging and Follow-up Vascular Imaging in Stroke Patients Birgit Ertl-Wagner, Tobias Brandt, Christina Seifart,
More informationSite of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke
Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke Maher Saqqur, MD, FRCPC; Ken Uchino, MD; Andrew M. Demchuk, MD, FRCPC; Carlos
More informationPrediction of Hemorrhage in Acute Ischemic Stroke Using Permeability MR Imaging
AJNR Am J Neuroradiol 26:2213 2217, October 2005 Technical Note Prediction of Hemorrhage in Acute Ischemic Stroke Using Permeability MR Imaging Andrea Kassner, Timothy Roberts, Keri Taylor, Frank Silver,
More informationAcute Stroke Treatment: Current Trends 2010
Acute Stroke Treatment: Current Trends 2010 Helmi L. Lutsep, MD Oregon Stroke Center Oregon Health & Science University Overview Ischemic Stroke Neuroprotectant trials to watch for IV tpa longer treatment
More informationMichael Horowitz, MD Pittsburgh, PA
Michael Horowitz, MD Pittsburgh, PA Introduction Cervical Artery Dissection occurs by a rupture within the arterial wall leading to an intra-mural Hematoma. A possible consequence is an acute occlusion
More informationLack of Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute Stroke JAMA. 2001;286:
ORIGINAL CONTRIBUTION Lack of Clinical Significance of Early Ischemic Changes on Computed Tomography in Acute Stroke Suresh C. Patel, MD Steven R. Levine, MD Barbara C. Tilley, PhD James C. Grotta, MD
More informationReduction of flow velocities in patients with ischemic events in the middle cerebral artery long-term follow-up with ultrasound
Acta Neurol. Belg., 20,, -5 Original articles Reduction of flow velocities in patients with ischemic events in the middle cerebral artery long-term follow-up with ultrasound Christine Kremer and Kasim
More informationBridging therapy (the combination of intravenous [IV] and
Bridging Therapy in Acute Ischemic Stroke A Systematic Review and Meta-Analysis Mikael Mazighi, MD, PhD; Elena Meseguer, MD; Julien Labreuche, BS; Pierre Amarenco, MD Background and Purpose Pending the
More informationCombined Intravenous and Intra-Arterial r-tpa Versus Intra-Arterial Therapy of Acute Ischemic Stroke
Combined Intravenous and Intra-Arterial r-tpa Versus Intra-Arterial Therapy of Acute Ischemic Stroke Emergency Management of Stroke (EMS) Bridging Trial Christopher A. Lewandowski, MD; Michael Frankel,
More informationSince the recombinant tissue plasminogen activator stroke
Thrombolysis With 0.6 mg/kg Intravenous Alteplase for Acute Ischemic Stroke in Routine Clinical Practice The Japan post-marketing Alteplase Registration Study (J-MARS) Jyoji Nakagawara, MD; Kazuo Minematsu,
More informationThrombolytic therapy for ischemic stroke A review. Part II Intra-arterial thrombolysis, vertebrobasilar stroke, phase IV trials, and stroke imaging
Thrombolytic therapy for ischemic stroke A review. Part II Intra-arterial thrombolysis, vertebrobasilar stroke, phase IV trials, and stroke imaging Peter D. Schellinger, MD; Jochen B. Fiebach, MD; Alexander
More informationIMAGING IN ACUTE ISCHEMIC STROKE
IMAGING IN ACUTE ISCHEMIC STROKE Timo Krings MD, PhD, FRCP (C) Professor of Radiology & Surgery Braley Chair of Neuroradiology, Chief and Program Director of Diagnostic and Interventional Neuroradiology;
More informationACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke
ACUTE ISCHEMIC STROKE Current Treatment Approaches for Acute Ischemic Stroke EARLY MANAGEMENT OF ACUTE ISCHEMIC STROKE Rapid identification of a stroke Immediate EMS transport to nearest stroke center
More informationBrain Attack. Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship. Case Medical Center
Brain Attack Strategies in the Management of Acute Ischemic Stroke: Neuroscience Clerkship Stroke is a common and devastating disorder Third leading antecedent of death in American men, and second among
More informationMechanical thrombectomy in Plymouth. Will Adams. Will Adams
Mechanical thrombectomy in Plymouth Will Adams Will Adams History Intra-arterial intervention 1995 (NINDS) iv tpa improved clinical outcome in patients treated within 3 hours of ictus but limited recanalisation
More informationMirroring its intravenous (IV) counterpart, much of the
REVIEW ARTICLE R.G. Nogueira A.J. Yoo F.S. Buonanno J.A. Hirsch Endovascular Approaches to Acute Stroke, Part 2: A Comprehensive Review of Studies and Trials SUMMARY: Reperfusion remains the mainstay of
More informationStroke is a strongly age-related disease, and the number of
ORIGINAL RESEARCH D. Kim G.A. Ford C.S. Kidwell S. Starkman F. Vinuela G.R. Duckwiler R. Jahan J.L. Saver, for the UCLA Intra- Arterial Thrombolysis Investigators Intra-Arterial Thrombolysis for Acute
More informationSignificant Relationships
Opening Large Vessels During Acute Ischemic Stroke Significant Relationships Wade S Smith, MD, PhD Director UCSF Neurovascular Service Professor of Neurology Daryl R Gress Endowed Chair of Neurocritical
More informationDownloaded from by on January 15, 2019
Alberta Stroke Program Early Computed Tomography Score to Select Patients for Endovascular Treatment Interventional Management of Stroke (IMS)-III Trial Michael D. Hill, MD, FRCPC; Andrew M. Demchuk, MD,
More informationIschemic stroke is a syndrome of multiple etiologies and
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Gregory W. Albers, MD, Chair; Pierre Amarenco, MD; J. Donald Easton, MD; Ralph L. Sacco, MD; and Philip Teal, MD Abbreviations: ACE ASA and Carotid
More informationOBJECTIVES: INTRODUCTION ADVANCES IN ACUTE STROKE CARE
Brian A. Stettler, MD Assistant Professor, Department of Emergency Medicine, University of Cincinnati College of Medicine Member, Greater Cincinnati/Northern Kentucky Stroke Team Cincinnati, Ohio OBJECTIVES:
More informationAcute basilar artery occlusion (BAO) is associated with a very
ORIGINAL RESEARCH INTERVENTIONAL Acute Basilar Artery Occlusion: Outcome of Mechanical Thrombectomy with Solitaire Stent within 8 Hours of Stroke Onset J.M. Baek, W. Yoon, S.K. Kim, M.Y. Jung, M.S. Park,
More informationThe Predictive Value of Early CT and Angiography for Fatal Hemispheric Swelling in Acute Stroke
AJNR Am J Neuroradiol 19:839 846, May 1998 The Predictive Value of Early CT and Angiography for Fatal Hemispheric Swelling in Acute Stroke Thomas Kucinski, Christoph Koch, Ulrich Grzyska, Heinz-Jörg Freitag,
More informationClinical Study Experiences of Thrombolytic Therapy for Ischemic Stroke in Tuzla Canton, Bosnia and Herzegovina
ISRN Stroke, Article ID 313976, 4 pages http://dx.doi.org/10.1155/2014/313976 Clinical Study Experiences of Thrombolytic Therapy for Ischemic Stroke in Tuzla Canton, Bosnia and Herzegovina DDevdet SmajloviT,DenisaSalihoviT,
More informationEndovascular Treatment for Acute Ischemic Stroke: Considerations from Recent Randomized Trials
Published online: March 13, 2015 1664 9737/15/0034 0115$39.50/0 Review Endovascular Treatment for Acute Ischemic Stroke: Considerations from Recent Randomized Trials Manabu Shirakawa a Shinichi Yoshimura
More informationPerils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion
Perils of Mechanical Thrombectomy in Acute Asymptomatic Large Vessel Occlusion Aman B. Patel, MD Robert & Jean Ojemann Associate Professor Director, Cerebrovascular Surgery Director, Neuroendovascular
More informationAcute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital
Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital STROKE IS THE MOST common cause of permanent disability in the Australian community The Medical
More informationStent-Assisted Recanalization for Acute Ischemic Stroke
Stent-Assisted Recanalization for Acute Ischemic Stroke Department of 1 Neurosurgery, 2 Diagnostic Radiology, Cerebrovascular Center, Yongdong Severance Hospital, Yonsei University College of Medicine,
More information